Risk association model for atelectasis complication in Mycoplasma pneumoniae pneumonia patients following standardized treatment

被引:0
|
作者
Xu, Mingyi [1 ,2 ,3 ]
Fan, Minhao [2 ,3 ]
Wang, Huixia [3 ,4 ]
Qian, Jun [2 ,3 ]
Jiang, Yi [2 ,3 ]
Zhu, Yifan [5 ]
Zhao, Deyu [5 ]
Liu, Feng [5 ]
Guo, Yun [2 ,3 ]
Li, Ling [1 ,2 ,3 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi Childrens Hosp, Dept Resp Med, Wuxi, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Childrens Hosp, Wuxi Childrens Hosp, Dept Resp Med, Wuxi, Peoples R China
[3] Jiangnan Univ, Affiliated Childrens Hosp, Wuxi Childrens Hosp, Clin Allergy Ctr, Wuxi, Peoples R China
[4] Zhumadian Cent Hosp, Dept Resp Med, Zhumadian, Henan, Peoples R China
[5] Nanjing Med Univ, Childrens Hosp, Dept Resp Med, Nanjing, Peoples R China
来源
FRONTIERS IN PEDIATRICS | 2024年 / 12卷
关键词
children; M; pneumoniae; M. pneumoniae pneumonia; atelectasis; association model; NECROTIZING PNEUMONIA; PREDICTION; CHILDREN;
D O I
10.3389/fped.2024.1422074
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Mycoplasma pneumoniae pneumonia (MPP) is a common disease of childhood pneumonia, and atelectasis is a serious comorbidity. Traditional diagnostic methods for MPP are limited by low accuracy, emphasizing the need for improved diagnostic approaches. This study aimed to establish a predictive scoring model for early detection of MPP complicated with atelectasis following standardized treatment. Methods: A total of 572 children were retrospectively enrolled, including 40 patients with MPP complicated by atelectasis despite standardized treatment and 532 patients in the non-atelectasis group. Clinical, laboratory, and imaging data within 24 h of admission were collected, including demographic information and various biomarkers. Multivariate logistic regression analysis was employed to identify risk factors and construct a predictive model, evaluated using receiver operating characteristic (ROC) curve analysis. Results: Significant differences were observed between the MPP complicated with atelectasis group and the non-atelectasis group in terms of age, hospital admission time, fever duration, neutrophil percentage and count, CRP, ALT, and LDH levels (P < 0.05). According to the multivariate logistic regression analysis, length of fever, neutrophil ratio, platelet count, ALT, LDH, age were incorporated into the nomogram. The predictive model exhibited a sensitivity of 87.97% and specificity of 77.50% according to the ROC curve. Conclusion: Our study presents a preliminary risk association model incorporating clinical indicators such as fever duration, neutrophil ratio, platelet count, ALT value, LDH value, and age to aid in the early prediction of atelectasis in children with MPP. Given the methodological limitations, the generalizability of our findings is constrained, and this model should be viewed as an initial framework for clinical assessment rather than a definitive tool.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Development of a model for early differentiation of adenovirus pneumonia from Mycoplasma pneumoniae pneumonia
    Zhang, Hu
    Li, Huajun
    Wang, Lijun
    Huang, Lisu
    Ma, Qibo
    Wu, Hanwen
    Pang, Huanchun
    Chen, Yiping
    Ruan, Zhengshang
    TRANSLATIONAL PEDIATRICS, 2022, 11 (11) : 1766 - 1775
  • [42] The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
    Dai, Fang-fang
    Liu, Feng-qin
    Chen, Xing
    Yang, Juan
    Wang, Ke
    Guo, Chun-yan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 705 - 710
  • [43] Study on childlike nursing in the treatment of children with mycoplasma pneumoniae pneumonia
    Zhou, Ru
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2024, 33 : 47 - 48
  • [44] Corticosteroid Treatment in Siblings Affected with Severe Mycoplasma pneumoniae Pneumonia
    Kim, Do-Hee
    Lee, Kyung-Yil
    Kim, Myung-Sook
    Youn, You-Sook
    Hwang, Ja-Young
    Rhim, Jung-Woo
    Kang, Jin-Han
    Lee, Joon-Sung
    INFECTION AND CHEMOTHERAPY, 2009, 41 (03): : 190 - 195
  • [45] Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literature
    Izumikawa, Koichi
    Izumikawa, Kinichi
    Takazono, Takahiro
    Kosai, Kosuke
    Morinaga, Yoshitomo
    Nakamura, Shigeki
    Kurihara, Shintaro
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Tsukamoto, Misuzu
    Yanagihara, Katsunbri
    Hara, Kohei
    Kohno, Shigeru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 181 - 185
  • [46] Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children
    Lee, KY
    Lee, HS
    Hong, JH
    Lee, MH
    Lee, JS
    Burgner, D
    Lee, BC
    PEDIATRIC PULMONOLOGY, 2006, 41 (03) : 263 - 268
  • [47] ROLE OF METHYLPREDNISOLONE TREATMENT IN SEVERE MYCOPLASMA PNEUMONIAE PNEUMONIA IN CHILDREN
    Wang, J.
    Ding, S. G.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S81 - S81
  • [48] Mycoplasma pneumoniae pneumonia in children: Clinical characteristics and risk factors of refractory pneumonia by age
    Kim, Hyung Young
    Park, Hee Ju
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2018, 6 (06): : 295 - 302
  • [49] SEARCH FOR MYCOPLASMA PNEUMONIAE INFECTION - IN PATIENTS WITH EXANTHEM BUT WITHOUT PNEUMONIA
    CHERRY, JD
    ALLEN, VD
    SUELTMANN, S
    ARCHIVES OF ENVIRONMENTAL HEALTH, 1968, 16 (06): : 911 - +
  • [50] Elevated serum transaminases in patients with Mycoplasma pneumoniae pneumonia -: Reply
    Daxboeck, F
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (12) : 1052 - 1054